192 related articles for article (PubMed ID: 33791155)
1. CHPF promotes malignancy of breast cancer cells by modifying syndecan-4 and the tumor microenvironment.
Liao WC; Yen HR; Chen CH; Chu YH; Song YC; Tseng TJ; Liu CH
Am J Cancer Res; 2021; 11(3):812-826. PubMed ID: 33791155
[TBL] [Abstract][Full Text] [Related]
2. Targeting chondroitin sulfate suppresses macropinocytosis of breast cancer cells by modulating syndecan-1 expression.
Yen HR; Liao WC; Chen CH; Su YA; Huang YW; Hsiao C; Chou YL; Chu YH; Shih PK; Liu CH
Mol Oncol; 2024 May; ():. PubMed ID: 38770553
[TBL] [Abstract][Full Text] [Related]
3. CHPF Regulates the Aggressive Phenotypes of Hepatocellular Carcinoma Cells via the Modulation of the Decorin and TGF-β Pathways.
Liu CH; Wu BR; Ho YJ; Chu YH; Hsu WC; Tseng TJ; Li JP; Liao WC
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809195
[TBL] [Abstract][Full Text] [Related]
4. Chondroitin polymerizing factor predicts a poor prognosis and promotes breast cancer progression via the upstream TGF-β1/SMAD3 and JNK axis activation.
Pan QF; Ouyang WW; Zhang MQ; He S; Yang SY; Zhang J
J Cell Commun Signal; 2023 Mar; 17(1):89-102. PubMed ID: 36042157
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics and Experimental Analysis of the Prognostic and Predictive Value of the CHPF Gene on Breast Cancer.
Li WW; Liu B; Dong SQ; He SQ; Liu YY; Wei SY; Mou JY; Zhang JX; Liu Z
Front Oncol; 2022; 12():856712. PubMed ID: 35372047
[TBL] [Abstract][Full Text] [Related]
6. Chondroitin Polymerizing Factor (CHPF) promotes cell proliferation and tumor growth in human osteosarcoma by inhibiting SKP2's ubiquitination while activating the AKT pathway.
Shen Y; Li J; Peng D; Liao L; Chen X; Zhong W; Liu Z; Yu C; Sun Y
Genes Dis; 2023 Sep; 10(5):2125-2136. PubMed ID: 37492722
[TBL] [Abstract][Full Text] [Related]
7. The HNF4A-CHPF pathway promotes proliferation and invasion through interactions with MAD1L1 in glioma.
Luo H; Huang K; Cheng M; Long X; Zhu X; Wu M
Aging (Albany NY); 2023 Oct; 15(20):11052-11066. PubMed ID: 37851364
[TBL] [Abstract][Full Text] [Related]
8. Chondroitin polymerizing factor (CHPF) promotes development of malignant melanoma through regulation of CDK1.
Sun W; Zhao F; Xu Y; Huang K; Guo X; Zheng B; Liu X; Luo Z; Kong Y; Xu M; Schadendorf D; Chen Y
Cell Death Dis; 2020 Jul; 11(7):496. PubMed ID: 32612115
[TBL] [Abstract][Full Text] [Related]
9. Exploring the correlation of glycolysis-related chondroitin polymerizing factor (
Zhong Q; Jiang K; Zhang F; Tian Y; Gu J; Li T; Chen X; Yang J; Sun F
Am J Cancer Res; 2023; 13(6):2213-2233. PubMed ID: 37424829
[TBL] [Abstract][Full Text] [Related]
10. Chondroitin polymerizing factor (CHPF) contributes to malignant proliferation and migration of hepatocellular carcinoma cells.
Xu Q; Lin W; Tao C; Huang X; Li J
Biochem Cell Biol; 2020 Jun; 98(3):362-369. PubMed ID: 32383983
[TBL] [Abstract][Full Text] [Related]
11. Expression of CHPF modulates cell proliferation and invasion in lung cancer.
Cao C; Liu Y; Wang Q; Zhao J; Shi M; Zheng J
Braz J Med Biol Res; 2020; 53(5):e9021. PubMed ID: 32348423
[TBL] [Abstract][Full Text] [Related]
12. Chondroitin polymerizing factor (CHPF) promotes the progression of colorectal cancer through ASB2-mediated ubiquitylation of SMAD9.
Zhao J; Tang X; Zhu H
Histol Histopathol; 2024 Mar; ():18738. PubMed ID: 38591191
[TBL] [Abstract][Full Text] [Related]
13. Glycogenes in Oncofetal Chondroitin Sulfate Biosynthesis are Differently Expressed and Correlated With Immune Response in Placenta and Colorectal Cancer.
Wu ZY; He YQ; Wang TM; Yang DW; Li DH; Deng CM; Cao LJ; Zhang JB; Xue WQ; Jia WH
Front Cell Dev Biol; 2021; 9():763875. PubMed ID: 34966741
[TBL] [Abstract][Full Text] [Related]
14. CHPF promotes lung adenocarcinoma proliferation and anti-apoptosis via the MAPK pathway.
Hou XM; Zhang T; Da Z; Wu XA
Pathol Res Pract; 2019 May; 215(5):988-994. PubMed ID: 30826152
[TBL] [Abstract][Full Text] [Related]
15. Involvement of chondroitin sulfate synthase-3 (chondroitin synthase-2) in chondroitin polymerization through its interaction with chondroitin synthase-1 or chondroitin-polymerizing factor.
Izumikawa T; Uyama T; Okuura Y; Sugahara K; Kitagawa H
Biochem J; 2007 May; 403(3):545-52. PubMed ID: 17253960
[TBL] [Abstract][Full Text] [Related]
16. Role for chondroitin sulfate glycosaminoglycan in NEDD9-mediated breast cancer cell growth.
Iida J; Dorchak J; Clancy R; Slavik J; Ellsworth R; Katagiri Y; Pugacheva EN; van Kuppevelt TH; Mural RJ; Cutler ML; Shriver CD
Exp Cell Res; 2015 Jan; 330(2):358-370. PubMed ID: 25445787
[TBL] [Abstract][Full Text] [Related]
17. Autotaxin-β interaction with the cell surface via syndecan-4 impacts on cancer cell proliferation and metastasis.
Leblanc R; Sahay D; Houssin A; Machuca-Gayet I; Peyruchaud O
Oncotarget; 2018 Sep; 9(69):33170-33185. PubMed ID: 30237860
[TBL] [Abstract][Full Text] [Related]
18. Expression of chondroitin/dermatan sulfate glycosyltransferases during early zebrafish development.
Filipek-Górniok B; Holmborn K; Haitina T; Habicher J; Oliveira MB; Hellgren C; Eriksson I; Kjellén L; Kreuger J; Ledin J
Dev Dyn; 2013 Aug; 242(8):964-75. PubMed ID: 23703795
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning of a chondroitin polymerizing factor that cooperates with chondroitin synthase for chondroitin polymerization.
Kitagawa H; Izumikawa T; Uyama T; Sugahara K
J Biol Chem; 2003 Jun; 278(26):23666-71. PubMed ID: 12716890
[TBL] [Abstract][Full Text] [Related]
20. Lentivirus‑mediated knockdown of chondroitin polymerizing factor inhibits glioma cell growth in vitro.
Fan YH; Xiao B; Lv SG; Ye MH; Zhu XG; Wu MJ
Oncol Rep; 2017 Aug; 38(2):1149-1155. PubMed ID: 28627702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
